The Government of New South Wales, the University of Sydney, Chris O`Brien Lifehouse, and Tilray announced a groundbreaking research partnership today to develop a novel treatment for chemotherapy-induced nausea and vomiting (CINV). Tilray is providing a proprietary capsule formulation for the proposed trial, which will allow researchers to test an investigational product containing two active ingredients extracted from the cannabis plant, cannabidiol (CBD) and tetrahydrocannabinol (THC). Continue reading Tilray Announces a Clinical Trial Partnership in Australia
Category Archives: Cannabis
Dose-related neurocognitive effects of marijuana use
by K.I. Bolla PhD, K. Brown MPH, D. Eldreth BA, K. Tate BA and J.L. Cadet MD
doi: http://dx.doi.org/10.1212/01.WNL.0000031422.66442.49
Neurology November 12, 2002 vol. 59 no. 9 1337-1343
Background: Although about 7 million people in the US population use marijuana at least weekly, there is a paucity of scientific data on persistent neurocognitive effects of marijuana use.
Objective: To determine if neurocognitive deficits persist in 28-day abstinent heavy marijuana users and if these deficits are dose-related to the number of marijuana joints smoked per week.
Methods: A battery of neurocognitive tests was given to 28-day abstinent heavy marijuana abusers.
Results: As joints smoked per week increased, performance decreased on tests measuring memory, executive functioning, psychomotor speed, and manual dexterity. When dividing the group into light, middle, and heavy user groups, the heavy group performed significantly below the light group on 5 of 35 measures and the size of the effect ranged from 3.00 to 4.20 SD units. Duration of use had little effect on neurocognitive performance.
Conclusions: Very heavy use of marijuana is associated with persistent decrements in neurocognitive performance even after 28 days of abstinence. It is unclear if these decrements will resolve with continued abstinence or become progressively worse with continued heavy marijuana use.
Source: neurology.org
Share this:
Adverse health effects of non-medical cannabis use
By Prof Wayne Hall PhD, Prof Louisa Degenhardt PhD
For over two decades, cannabis, commonly known as marijuana, has been the most widely used illicit drug by young people in high-income countries, and has recently become popular on a global scale.
Epidemiological research during the past 10 years suggests that regular use of cannabis during adolescence and into adulthood can have adverse effects.
Epidemiological, clinical, and laboratory studies have established an association between cannabis use and adverse outcomes. We focus on adverse health effects of greatest potential public health interest—that is, those that are most likely to occur and to affect a large number of cannabis users.
The most probable adverse effects include
- a dependence syndrome,
- increased risk of motor vehicle crashes,
- impaired respiratory function,
- cardiovascular disease, and
- adverse effects of regular use on adolescent psycho-social development and
- mental health.
Source: The Lancet
Share this:
Lessons from a pot investing summit
The peaks and pitfalls of pot investing
by Amanda Drury | @MandyCNBC Friday, 18 Dec 2015 | 1:45 PM
It wasn’t so many years ago that the words “cannabis gathering” only meant a joint being passed around the room and some sturdy philosophizing about life, the universe, and the bounties of the magic leaf. The picture could not have been more removed from that at the Cannabis Private Investment Summit organized by Kahner Global in New York City a couple of weeks ago. This was a room full of professional suits. On the one side, there were private family offices and high net worth investors potentially wanting to latch on to the exploding legal cannabis industry. On the other side, individuals with established cannabis-related companies pitching their products or services, informing and educating everyone about the opportunities in the space. Continue reading Lessons from a pot investing summit
Share this:
Health minister’s medical marijuana plan gets underway
Litzman’s overhaul includes training doctors who will be able to prescribe cannabis, and making it available in pharmacies
Continue reading Health minister’s medical marijuana plan gets underway
The Loud Cry 